Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of <i>in Vitro</i> Bladder Epithelial Cell Infection

The application of urinary catheters is associated with pain and discomfort. Several topical medications are available to ease catheter insertion, including xylocaine. Here we report that xylocaine, although not classified as an antibacterial agent, has bacteriostatic properties against both Gram-positive and Gram-negative etiological agents of urinary tract infections (UTIs). Xylocaine reduces the amount of biofilm formed by ESBL- and non-ESBL-producing <i>E. coli</i>. In addition, xylocaine possesses slight immunomodulatory properties in uroepithelial cells, and treatment of uroepithelial cells prior to infection reduces bacterial loads in the supernatant. In conclusion, xylocaine has multifaceted positive effects when used during the insertion of urinary catheters.

Authors

Institutions

Publication Details

Journal
ACS Bio & Med Chem Au
Published
2024-12-16
DOI
https://doi.org/10.1021/acsbiomedchemau.4c00070
Primary Topic
Urinary Tract Infections Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of in Vitro Bladder Epithelial Cell Infection

Soumitra Mohanty, Natália Ferraz, Annelie Brauner, John Kerr White et al.
ACS Bio & Med Chem Au
Urinary Tract Infections Management
article

Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of in Vitro Bladder Epithelial Cell Infection

Soumitra Mohanty, Natália Ferraz, Annelie Brauner, John Kerr White, Yanfeng Yin
article en

Abstract

The application of urinary catheters is associated with pain and discomfort. Several topical medications are available to ease catheter insertion, including xylocaine. Here we report that xylocaine, although not classified as an antibacterial agent, has bacteriostatic properties against both Gram-positive and Gram-negative etiological agents of urinary tract infections (UTIs). Xylocaine reduces the amount of biofilm formed by ESBL- and non-ESBL-producing <i>E. coli</i>. In addition, xylocaine possesses slight immunomodulatory properties in uroepithelial cells, and treatment of uroepithelial cells prior to infection reduces bacterial loads in the supernatant. In conclusion, xylocaine has multifaceted positive effects when used during the insertion of urinary catheters.

ACS Bio & Med Chem AuVol. 5(1)
Uppsala University (SE), Karolinska University Hospital (SE), Karolinska Institutet (SE), Institute of Molecular Functional Materials (CN), Czech Academy of Sciences, Institute of Microbiology (CZ)
Karolinska Institutet
Zero hunger
Openalex Percentile: Top 65%
Urinary Tract Infections Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Bacteriostatic and Immunomodulatory Effect of Xylocaine in the Context of <i>in Vitro</i> Bladder Epithelial Cell Infection — Soumitra Mohanty, Natália Ferraz, et al. · ACS Bio & Med Chem Au (2024) | TGRS Research Map | TGRS